CSBR vs SPG · P/E 16, rev $59.4M vs rev $3.55B
Champions Oncology Inc (CSBR) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported CSBR revenue for 2026-04-30 was $59.4M. Net income was -$1.2M. Revenue was up 4.4% from 2025-04-30 to 2026-04-30. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. SPG currently screens at market cap $0.
Not investment advice. Open the CSBR and SPG stock pages for the full models.
Not investment advice.